A simple whole cell based high throughput screening protocol using Mycobacterium bovis BCG for inhibitors against dormant and active tubercle bacilli

Journal of Microbiological Methods

Volumn 73, Issue 1, 2008, Pages 62-68

  Khan, Arshad ^a   Sarkar, Dhiman ^a  

^a NATIONAL CHEMICAL LABORATORY   (India)

Author keywords

High throughput screening; Tuberculosis; Wayne's dormancy model; Whole cell based assay

Indexed keywords

ANTIMYCOBACTERIAL AGENT; AZIDE; ETHAMBUTOL; ISONIAZID; ITACONIC ACID; METRONIDAZOLE; RIFAMPICIN; STREPTOMYCIN; THIOCYANATE;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; DRUG SCREENING; IN VITRO STUDY; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SCREENING; WHOLE CELL;

ANIMALS; ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; CATTLE; CULTURE MEDIA; DIMETHYL SULFOXIDE; DRUG EVALUATION, PRECLINICAL; ENZYME INHIBITORS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NITRATE REDUCTASES;

BACILLI (CLASS); MYCOBACTERIUM BOVIS BCG;

EID: 40849114279     PISSN: 01677012     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mimet.2008.01.015     Document Type: Article

References (31)

1. Arain T.M., Resconi A.E., Hickey M.J., and Stover C.K. Bioluminescence screening in vitro (Bio-Siv) assays for high-volume antimycobacterial drug discovery. Antimicrob. Agents Chemother. 40 (1996) 1536-1541
2. Betts J.C., Lukey P.T., Robbs L.C., McAdam R.A., and Duncan K. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol. Microbiol. 43 (2002) 717-731
3. Changsen C., Franzblau S.G., and Palittapongarnpim P. Improved green fluorescent protein reporter gene-based microplate screening for antituberculosis compounds by utilizing an acetamidase promoter. Antimicrob. Agents Chemother. 47 (2003) 3682-3687
4. Chung G.A.C., Aktar Z., Jackson S., and Duncan K. High-throughput screening for detecting antimycobacterial agents. Antimicrob. Agents Chemother. 39 (1995) 2235-2238
5. Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C., Harris D., Gordon S.V., Eiglmeier K., Gas S., Barry III C.E., Tekaia F., Badcock K., Basham D., Brown D., Chillingworth T., Connor R., Davies R., Devlin K., Feltwell T., Gentles S., Hamlin N., Holroyd S., Hornsby T., Jagels K., Krogh A., McLean J., Moule S., Murphy L., Oliver K., Osborne J., Quail M.A., Rajandream M.A., Rogers J., Rutter S., Seeger K., Skelton J., Squares R., Squares S., Sulston J.E., Taylor K., Whitehead S., and Barrell B.G. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393 (1998) 537544
6. Collins L., and Franzblau S.G. Microplate Alamar Blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob. Agents Chemother. 41 (1997) 1004-1009
7. Dick T., Lee B.H., Murugasu, and Oei B. Oxygen depletion induced dormancy in Mycobacterium smegmatis. FEMS Microbiol. Lett. 163 (1998) 159-164
8. Fritz C., Maass S., Kreft A., and Bange F.C. Dependence of Mycobacterium bovis BCG on anaerobic nitrate reductase for persistence is tissue specific. Infect. Immun. 70 (2002) 286-291
9. Garnier T., Eiglmeier K., Camus J.C., Medina N., Mansoor H., Pryor M., Duthoy S., Grondin S., Lacroix C., Monsempe C., Simon S., Harris B., Atkin R., Doggett J., Mayes R., Keating L., Wheeler P.R., Parkhill J., Barrell B.G., Cole S.T., Gordon S.V., and Hewinson R.G. The complete genome sequence of Mycobacterium bovis. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 7877-7882
10. Honer Zu Bentrup K., Miczak A., Swenson D.L., and Russell D.G. Characterization of activity and expression of isocitrate lyase in Mycobacterium avium and Mycobacterium tuberculosis. J. Bacteriol. 181 (1999) 7161-7167
11. Khan A., and Sarkar D. Identification of a respiratory-type nitrate reductase and its role for survival of Mycobacterium smegmatis in Wayne model. Microb. Pathog. 41 (2006) 90-95
12. Lim A., Eleuterio M., Hutter B., Murugasu-Oei B., and Dick T. Oxygen depletion-induced dormancy in Mycobacterium bovis BCG. J. Bacteriol. 181 (1999) 2252-2256
13. Manabe Y.C., and Bishai W.R. Latent Mycobacterium tuberculosis - persistence, patience, and winning by waiting. Nat. Med. 6 (2000) 1327-1329
14. Moreno-Vivián C., Cabello P., Martínez-Luque M., Blasco R., and Castillo F. Prokaryotic nitrate reduction: molecular properties and functional distinction among bacterial nitrate reductases. J. Bacteriol. 181 (1999) 6573-6584
15. Nicholas D.J.D., and Nason A. Determination of nitrate and nitrite. Methods. Enzymol. 3 (1957) 981-984
16. Parrish N.M., Dick J.D., and Bishai W.R. Mechanisms of latency in Mycobacterium tuberculosis. Trends Microbiol. 6 (1998) 107-112
17. Roberts G.D., Goodman N.L., and Heifets L. Evaluation of the BACTEC Radiometric method for recovery of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis from acid-fast smear-positive specimens. J. Clin. Microbiol. 18 (1983) 689-696
18. Schluger N.W. The impact of drug resistance on the global tuberculosis epidemic. Int. J. Tuberc. Lung. Dis. 4 (2000) S71-S75
19. Shawar R.M., Humble D.J., Van Dalfsen J.M., Stover C.K., Hickey M.J., Steele S., Mitscher L.A., and Baker W. Rapid screening of natural products for antimycobacterial activity by using luciferase-expressing strains of Mycobacterium bovis BCG and Mycobacterium intracellulare. Antimicrob. Agents Chemother. 41 (1997) 570-574
20. Srivastava R., Kumar D., and Srivastava B.S. Recombinant Mycobacterium aurum expressing Escherichia coli b-galactosidase in high throughput screening of antituberculosis drugs. Biochem. Biophys. Res. Commun. 240 (1997) 536-539
21. Takii T., Yamamoto Y., Chiba T., Abe C., Belisle J.T., Brennan P.J., and Onozaki K. Simple fibroblast-based assay for screening of new antimicrobial drugs against Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 46 (2002) 2533-2539
22. Taneja N.K., and Tyagi J.S. Resazurin reduction assays for screening of anti-tubercular compounds against dormant and actively growing Mycobacterium tuberculosis, Mycobacterium bovis BCG and Mycobacterium smegmatis. J. Antimicrob. Chemother. 60 (2007) 288-293
23. Wallace Jr. R.J., Nash D.R., Steele L.C., and Steingrube V. Susceptibility testing of slowly growing mycobacteria by a microdilution MIC method with 7H9 broth. J. Clin. Microbiol. 24 (1986) 976-981
24. Wayne L.G. Dormancy of Mycobacterium tuberculosis and latency of disease. Eur. J. Clin. Microbiol. Infect. Dis. 13 (1994) 908-914
25. Wayne L.G., and Sramek H.A. Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 38 (1994) 2054-2058
26. Wayne L.G., and Hayes L.G. An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of non-replicating persistence. Infect. Immun. 64 (1996) 2062-2069
27. Wayne L.G., and Hayes L.G. Nitrate reduction as a marker for hypoxic shift down of Mycobacterium tuberculosis. Tubercle Lung. Dis. 79 (1998) 127-132
28. Wayne L.G., and Sohaskey C.D. Non-replicating persistence of Mycobacterium tuberculosis. Annu. Rev. Microbiol. 55 (2001) 139-163
29. Weber I., Fritz C., Ruttkowski S., Dreft A., and Bange F.C. Anaerobic nitrate reductase (narGHJI) activity of Mycobacterium bovis BCG in vitro and its contribution to virulence in immunodeficient mice. Mol. Microbiol. 35 (2000) 1017-1025
30. World Health Organization. Global tuberculosis control: surveillance, planning, financing. WHO Report (2005), World Health Organization, Geneva, Switzerland
31. Zhang J.H., Chung T.D.Y., and Oldenburg K.R. A simple statistical parameter for use in evaluation and validation of high-throughput screening assays. J. Biomol. Screen. 4 (1999) 67-73